| Janay D Taylor, | |
|
801 Cromwell Park Dr Ste 11, Glen Burnie, MD 21061-2539 | |
| (240) 949-6808 | |
| Not Available |
| Full Name | Janay D Taylor |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 801 Cromwell Park Dr Ste 11, Glen Burnie, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659974707 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 22515 (Maryland) | Primary |
| Entity Name | Jewish Social Service Agency |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962414284 PECOS PAC ID: 8123920097 Enrollment ID: O20040121001177 |
News Archive
Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell.
On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.
A research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute has discovered a new class of small-molecule compounds that are good candidates for development of novel targeted therapies in the treatment of leukemia and lymphoma.
At a press conference in London, health officials said that the anticipated roll-out of the MenAfriVac for meningitis in three African countries will start on Dec. 6, the BBC reports.
Astex Pharmaceuticals, Inc., today reported financial results for the fourth quarter and year ended December 31, 2011.
› Verified 9 days ago
| Entity Name | Thrive Counseling Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215181300 PECOS PAC ID: 0749458420 Enrollment ID: O20180531001919 |
News Archive
Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell.
On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.
A research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute has discovered a new class of small-molecule compounds that are good candidates for development of novel targeted therapies in the treatment of leukemia and lymphoma.
At a press conference in London, health officials said that the anticipated roll-out of the MenAfriVac for meningitis in three African countries will start on Dec. 6, the BBC reports.
Astex Pharmaceuticals, Inc., today reported financial results for the fourth quarter and year ended December 31, 2011.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Janay D Taylor, 1000 Jefferson St Ste 2c, Lynchburg, VA 24504-1724 Ph: () - | Janay D Taylor, 801 Cromwell Park Dr Ste 11, Glen Burnie, MD 21061-2539 Ph: (240) 949-6808 |
News Archive
Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell.
On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval from the Administration.
A research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute has discovered a new class of small-molecule compounds that are good candidates for development of novel targeted therapies in the treatment of leukemia and lymphoma.
At a press conference in London, health officials said that the anticipated roll-out of the MenAfriVac for meningitis in three African countries will start on Dec. 6, the BBC reports.
Astex Pharmaceuticals, Inc., today reported financial results for the fourth quarter and year ended December 31, 2011.
› Verified 9 days ago
Deadra Carnack Atkins, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 122 Langley Rd N, Suite A, Glen Burnie, MD 21060 Phone: 410-222-6785 | |
David A Nunez, LMSW, CAC-AD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 102 6th Ave Ne Ste B, Glen Burnie, MD 21060 Phone: 410-320-9967 Fax: 443-835-3925 | |
Ashley Nicole Palestis, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 122 Langley Rd N Ste A, Glen Burnie, MD 21060 Phone: 410-222-6785 | |
Janet Silber, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 30 Greenway St Nw Ste 5, Glen Burnie, MD 21061 Phone: 410-760-9079 | |
Vicki Fearey, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7310 Ritchie Highway, Suite 1009, Glen Burnie, MD 21061 Phone: 410-768-5988 | |
Kelly Hoenshell, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 217 Allen Rd, Glen Burnie, MD 21061 Phone: 443-557-8730 | |
Kristilee P Sheffler, LGSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 804 Landmark Dr, Suite 118, Glen Burnie, MD 21061 Phone: 410-863-7213 Fax: 410-863-7205 |